PATENT CLAIM ANALYSIS

Application Number: 15928906
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["562", "495000"]

Abstract:
A method for producing a compound of formula (I) or a pharmaceutically acceptable salt, solvate, tautomer or stereoisomer, such as compound 1 and compound 2 is disclosed. The method proceeds through an O-allylated tyrosine-based compound, such as compound 3 and preferably comprises [3,3] sigmatropic Claisen rearrangement and olefin cross metathesis reactions. In addition, a pharmaceutical composition comprising a compound of formula (I) a tumor necrosis factor (TNF) related apoptosis inducing ligand (TRAIL) and a pharmaceutically acceptable carrier or excipient is disclosed.

Claim (Index 6):
The method of  claim 1 , wherein the olefin cross metathesizing is performed at temperatures of at least 20\u00b0 C.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.59677
- Patent Class: 562.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14918658', '12093867', '13771546', '15398851', '12093874']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6871446238819168
- 35 USC 102 Novelty (BERT): 0.561375487485093
- Combined Prediction Score: 0.6745677102422344
- Mean Citation Score: 271.73047
- Max Citation Score: 399.2035
- Similarity Product: 397.209316571027

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test